342 related articles for article (PubMed ID: 32507576)
21. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
23. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
[TBL] [Abstract][Full Text] [Related]
24. Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells.
de Andrade AV; Riewaldt J; Wehner R; Schmitz M; Odendahl M; Bornhäuser M; Tonn T
J Cell Mol Med; 2014 Jun; 18(6):1184-93. PubMed ID: 24655362
[TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stromal cells from amniotic fluid are less prone to senescence compared to those obtained from bone marrow: An in vitro study.
Alessio N; Pipino C; Mandatori D; Di Tomo P; Ferone A; Marchiso M; Melone MAB; Peluso G; Pandolfi A; Galderisi U
J Cell Physiol; 2018 Nov; 233(11):8996-9006. PubMed ID: 29904927
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
[TBL] [Abstract][Full Text] [Related]
27. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
[TBL] [Abstract][Full Text] [Related]
28. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
Najar M; Raicevic G; Boufker HI; Fayyad-Kazan H; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2010 Nov; 16(11):3537-46. PubMed ID: 20597819
[TBL] [Abstract][Full Text] [Related]
29. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival
Lu X; Ru Y; Chu C; Lv Y; Gao Y; Jia Z; Huang Y; Zhang Y; Zhao S
Theranostics; 2020; 10(18):8446-8467. PubMed ID: 32724480
[No Abstract] [Full Text] [Related]
32. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
33. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
34. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
Erpicum P; Weekers L; Detry O; Bonvoisin C; Delbouille MH; Grégoire C; Baudoux E; Briquet A; Lechanteur C; Maggipinto G; Somja J; Pottel H; Baron F; Jouret F; Beguin Y
Kidney Int; 2019 Mar; 95(3):693-707. PubMed ID: 30528263
[TBL] [Abstract][Full Text] [Related]
35. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
36. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
37. Human mesenchymal stromal cells from adult and neonatal sources: a comparative in vitro analysis of their immunosuppressive properties against T cells.
Castro-Manrreza ME; Mayani H; Monroy-García A; Flores-Figueroa E; Chávez-Rueda K; Legorreta-Haquet V; Santiago-Osorio E; Montesinos JJ
Stem Cells Dev; 2014 Jun; 23(11):1217-32. PubMed ID: 24428376
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.
Girdlestone J; Pido-Lopez J; Srivastava S; Chai J; Leaver N; Galleu A; Lombardi G; Navarrete CV
Cytotherapy; 2015 Sep; 17(9):1188-99. PubMed ID: 26276002
[TBL] [Abstract][Full Text] [Related]
39. TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival
Murphy N; Treacy O; Lynch K; Morcos M; Lohan P; Howard L; Fahy G; Griffin MD; Ryan AE; Ritter T
FASEB J; 2019 Aug; 33(8):9404-9421. PubMed ID: 31108041
[TBL] [Abstract][Full Text] [Related]
40. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
